Melissa-Rosina Pasqua
Research Institute of the McGill University Health Centre Royal Victoria Hospital · McGill University Health Centre/Research Institute of the McGill University Health Centre · Division of Endocrinology and Metabolism - McGill University Health Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Melissa-Rosina Pasqua as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:23 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07891156 · Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.McGill University Health Centre/Research Institute of the McGill University Health Centre · recruiting · Type 1 Diabetes, Overweight , Obesity · principal investigator
- Ph2/Ph3NCT07284511 · A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarMcGill University Health Centre/Research Institute of the McGill University Health Centre · recruiting · Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D · principal investigator
- Ph3NCT06894784 · A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · recruiting · Diabetes Type 1 · study director
- N/ANCT06420518 · Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy.McGill University · completed · type1diabetes · principal investigator
- Ph2/Ph3NCT06046417 · A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · type1diabetes, Diabetes Mellitus, Type 1 · study chair
- Ph4NCT06021145 · Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic OutcomesMcGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · Type 1 Diabetes · principal investigator
- Ph2NCT06021158 · A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · Diabetes Mellitus, Type 1, Type 1 Diabetes · study chair
- Ph1NCT04450563 · Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin SystemMcGill University · completed · Type 1 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:23 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.N Engl J Med · 202570 citationsRCR 19.3
- 60 citationsRCR 14.3
- 42 citationsRCR 1.8
- Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial.Diabetes Care · 202319 citationsRCR 2.1
- Effects of liposomal nasal spray with vitamins A and E on allergic rhinitis.Acta Otorhinolaryngol Ital · 20206 citationsRCR 0.4
- Participant Experiences of Low-Dose Empagliflozin Use as Adjunct Therapy to Hybrid Closed Loop: Findings From a Randomized Controlled Trial.J Diabetes Sci Technol · 20232 citationsRCR 0.2
- A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System.J Diabetes Sci Technol · 20250 citationsRCR 0.0